Cargando…
A comprehensive overview on antibody-drug conjugates: from the conceptualization to cancer therapy
Antibody-Drug Conjugates (ADCs) represent an innovative class of potent anti-cancer compounds that are widely used in the treatment of hematologic malignancies and solid tumors. Unlike conventional chemotherapeutic drug-based therapies, that are mainly associated with modest specificity and therapeu...
Autores principales: | Riccardi, Federico, Dal Bo, Michele, Macor, Paolo, Toffoli, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544916/ https://www.ncbi.nlm.nih.gov/pubmed/37790810 http://dx.doi.org/10.3389/fphar.2023.1274088 |
Ejemplares similares
-
Novel Nanotechnology Approaches to Overcome Drug Resistance in the Treatment of Hepatocellular Carcinoma: Glypican 3 as a Useful Target for Innovative Therapies
por: Mossenta, Monica, et al.
Publicado: (2022) -
Nanoparticles-Based Oligonucleotides Delivery in Cancer: Role of Zebrafish as Animal Model
por: Bozzer, Sara, et al.
Publicado: (2021) -
The Proteoglycan Glypican-1 as a Possible Candidate for Innovative Targeted Therapeutic Strategies for Pancreatic Ductal Adenocarcinoma
por: Busato, Davide, et al.
Publicado: (2022) -
Nanocarriers as a Delivery Platform for Anticancer Treatment: Biological Limits and Perspectives in B-Cell Malignancies
por: Bozzer, Sara, et al.
Publicado: (2022) -
Zebrafish: A Useful Animal Model for the Characterization of Drug-Loaded Polymeric NPs
por: Bozzer, Sara, et al.
Publicado: (2022)